{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:28:23Z","timestamp":1793946503576,"version":"4.8.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003093","name":"Malaysia Ministry of Higher Education","doi-asserted-by":"publisher","award":["FRGS\/1\/2025\/SKK06\/USM\/02\/4"],"award-info":[{"award-number":["FRGS\/1\/2025\/SKK06\/USM\/02\/4"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.critrevonc.2026.105513","type":"journal-article","created":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T22:09:59Z","timestamp":1785708599000},"page":"105513","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Decoding context-dependent sirtuin pharmacology in cancer: Metabolic\u2013epigenetic switches and precision therapeutic targeting"],"prefix":"10.1016","volume":"226","author":[{"given":"Abdelwahab","family":"Aly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqing","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7705-1418","authenticated-orcid":false,"given":"Sreenivasan","family":"Sasidharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4685-6408","authenticated-orcid":false,"given":"Chern Ein","family":"Oon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.critrevonc.2026.105513_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107722","article-title":"Multifaceted regulation of sirtuin 2 (Sirt2) deacetylase activity","volume":"300","author":"Abeywardana","year":"2024","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105513_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/ph18111723","article-title":"Sirtuins as therapeutic targets for treating cancer, metabolic diseases, and neurodegenerative diseases","volume":"18","author":"Akantibila","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105513_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-49199-7","article-title":"SIRT6 promotes metastasis and relapse in HER2-positive breast cancer","volume":"13","author":"Andreani","year":"2023","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105513_bib4","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1002\/ijc.33871","article-title":"SIRT1-mediated deacetylation of FOXO3a transcription factor supports pro-angiogenic activity of interferon-deficient tumor-associated neutrophils","volume":"150","author":"Bordbari","year":"2022","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105513_bib5","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1080\/14756366.2020.1758691","article-title":"Biochemical mechanism and biological effects of the inhibition of silent information regulator 1 (SIRT1) by EX-527 (SEN0014196 or selisistat)","volume":"35","author":"Broussy","year":"2020","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.critrevonc.2026.105513_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107984","article-title":"SIRT6 in health and diseases: From molecular mechanisms to therapeutic prospects","author":"Chen","year":"2025","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105513_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2025.100973","article-title":"SIRT3 Functions as an Eraser of Histone H3K9 Lactylation to Modulate Transcription for Inhibiting the Progression of Esophageal Cancer","volume":"24","author":"Chen","year":"2025","journal-title":"Mol. & Cell. Proteom."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105513_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23063212","article-title":"Mitochondrial sirtuins in chronic degenerative diseases: new metabolic targets in colorectal cancer","volume":"23","author":"Colloca","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105513_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.758320","article-title":"Insight Into nicotinamide adenine dinucleotide homeostasis as a targetable metabolic pathway in colorectal cancer","volume":"12","author":"Colombo","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.critrevonc.2026.105513_bib10","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.pharmthera.2018.03.004","article-title":"Sirtuin activators and inhibitors: promises, achievements, and challenges","volume":"188","author":"Dai","year":"2018","journal-title":"Pharmacol. & Ther."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105513_bib11","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/1097-0142(19950115)75:2<440::AID-CNCR2820750205>3.0.CO;2-3","article-title":"Suramin in patients with metastatic colorectal cancer pretreated with fluoropyrimidine-based chemotherapy. A phase II study","volume":"75","author":"Falcone","year":"1995","journal-title":"Cancer"},{"issue":"741","key":"10.1016\/j.critrevonc.2026.105513_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adj5705","article-title":"TSPAN8+ myofibroblastic cancer\u2013associated fibroblasts promote chemoresistance in patients with breast cancer","volume":"16","author":"Fan","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"19","key":"10.1016\/j.critrevonc.2026.105513_bib13","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1158\/0008-5472.CAN-12-1949","article-title":"Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay","volume":"72","author":"Fiaschi","year":"2012","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105513_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/molecules30081728","article-title":"Lead-structure-based rigidization approach to optimize SirReal-type Sirt2 inhibitors","volume":"30","author":"Frei","year":"2025","journal-title":"Molecules"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105513_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049761","article-title":"A molecular mechanism for direct sirtuin activation by resveratrol","volume":"7","author":"Gertz","year":"2012","journal-title":"PLoS. One"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105513_bib16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41590-025-02377-3","article-title":"SIRT2-mediated deacetylation of LCK governs the magnitude of T cell receptor signaling","volume":"27","author":"Hamaidi","year":"2026","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105513_bib17","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.cmet.2020.07.008","article-title":"Sirt2 Inhibition Enhances Metabolic Fitness and Effector Functions of Tumor-Reactive T Cells","volume":"32","author":"Hamaidi","year":"2020","journal-title":"Cell. Metab."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105513_bib18","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s13578-023-01113-4","article-title":"The SIRT7-mediated deacetylation of CHD1L amplifies HIF-2\u03b1-dependent signal that drives renal cell carcinoma progression and sunitinib resistance","volume":"13","author":"He","year":"2023","journal-title":"Cell. & Biosci."},{"key":"10.1016\/j.critrevonc.2026.105513_bib19","doi-asserted-by":"crossref","DOI":"10.1177\/09603271241266106","article-title":"Sulforaphane triggers Sirtuin 3-mediated ferroptosis in colorectal cancer cells via activating the adenosine 5\u2018-monophosphate (AMP)-activated protein kinase\/ mechanistic target of rapamycin signaling pathway","volume":"43","author":"Hu","year":"2024","journal-title":"Human. & Exp. Toxicol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105513_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41419-018-1260-z","article-title":"Inhibition of SIRT2 limits tumour angiogenesis via inactivation of the STAT3\/VEGFA signalling pathway","volume":"10","author":"Hu","year":"2018","journal-title":"Cell. Death & Dis."},{"key":"10.1016\/j.critrevonc.2026.105513_bib21","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-025-02533-1","article-title":"Cancer-associated fibroblasts in the tumor microenvironment: heterogeneity, crosstalk mechanisms, and therapeutic implications","author":"Huang","year":"2025","journal-title":"Mol. Cancer"},{"issue":"19","key":"10.1016\/j.critrevonc.2026.105513_bib22","doi-asserted-by":"crossref","first-page":"17319","DOI":"10.1021\/acs.jmedchem.4c01223","article-title":"Discovery of Novel PROTAC SIRT6 Degraders with Potent Efficacy against Hepatocellular Carcinoma","volume":"67","author":"Huang","year":"2024","journal-title":"J. Med. Chem."},{"issue":"23","key":"10.1016\/j.critrevonc.2026.105513_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/cells13232023","article-title":"SIRT2 Inhibition by AGK2 Promotes Perinuclear Cytoskeletal Organisation and Reduces Invasiveness of MDA-MB-231 Triple-Negative Breast Cancer Cells in Confined In Vitro Models","volume":"13","author":"Jessop","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.critrevonc.2026.105513_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2026.07.026","article-title":"Dual targeting of SLC25A51 and succinate dehydrogenase selectively depletes mitochondrial NAD+ to eradicate KRAS-driven AML","author":"Jia","year":"2026","journal-title":"Cell. Metab."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105513_bib25","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/s41388-023-02592-y","article-title":"NAD+ supplementation limits triple-negative breast cancer metastasis via SIRT1-P66Shc signaling","volume":"42","author":"Jiang","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2026.105513_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216064","article-title":"The PIK3CA-E545K-SIRT4 signaling axis reduces radiosensitivity by promoting glutamine metabolism in cervical cancer","volume":"556","author":"Jiang","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2026.105513_bib27","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.3390\/molecules30102123","article-title":"PROTAC Technology as a New Tool for Modern Pharmacotherapy","author":"Kubry\u0144","year":"2025","journal-title":"Molecules"},{"issue":"25","key":"10.1016\/j.critrevonc.2026.105513_bib28","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2409269121","article-title":"SIRT7 promotes lung cancer progression by destabilizing the tumor suppressor ARF","volume":"121","author":"Kumari","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105513_bib29","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41392-025-02360-2","article-title":"Cancer stem cells: landscape, challenges and emerging therapeutic innovations","volume":"10","author":"Lee","year":"2025","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.critrevonc.2026.105513_bib30","series-title":"Sirtuin Biology in Cancer and Metabolic Disease","first-page":"153","article-title":"Chapter 9 - The bifunctional roles of sirtuins and their therapeutic potential in cancer","author":"Lee","year":"2021"},{"issue":"17","key":"10.1016\/j.critrevonc.2026.105513_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70053","article-title":"MitoAMPK inhibits the Warburg effect by MZF1-SIRT6 with glycosis related genes in NSCLC","volume":"28","author":"Li","year":"2024","journal-title":"J. Cell. Mol. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105513_bib32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neo.2020.11.013","article-title":"SUMOylation is essential for Sirt2 tumor-suppressor function in neuroblastoma","volume":"23","author":"Lu","year":"2021","journal-title":"Neoplasia"},{"issue":"20","key":"10.1016\/j.critrevonc.2026.105513_bib33","article-title":"SIRT4 Promotes Pancreatic Cancer Stemness by Enhancing Histone Lactylation and Epigenetic Reprogramming Stimulated by Calcium Signaling","volume":"12","author":"Lv","year":"2025","journal-title":"Adv. Sci. (Weinh. )"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105513_bib34","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/s41467-025-56529-y","article-title":"Structural basis of SIRT7 nucleosome engagement and substrate specificity","volume":"16","author":"Moreno-Yruela","year":"2025","journal-title":"Nat. Commun."},{"issue":"14","key":"10.1016\/j.critrevonc.2026.105513_bib35","article-title":"NAD(+)-Dependent Enzyme SIRT3 Limits Intestinal Epithelial Cell Functions Through NAD(+) Synthesis Pathway in Colorectal Cancer","volume":"13","author":"Niu","year":"2026","journal-title":"Adv. Sci. (Weinh. )"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105513_bib36","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1002\/mc.23809","article-title":"SIRT1 promotes doxorubicin-induced breast cancer drug resistance and tumor angiogenesis via regulating GSH-mediated redox homeostasis","volume":"63","author":"Sahoo","year":"2024","journal-title":"Mol. Carcinog."},{"issue":"16","key":"10.1016\/j.critrevonc.2026.105513_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241612618","article-title":"A Novel Transgenic Mouse Model Implicates Sirt2 as a Promoter of Hepatocellular Carcinoma","volume":"24","author":"Schmidt","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"17","key":"10.1016\/j.critrevonc.2026.105513_bib38","doi-asserted-by":"crossref","first-page":"6726","DOI":"10.7150\/thno.100667","article-title":"Targeting sirtuins for cancer therapy: epigenetics modifications and beyond","volume":"14","author":"Shen","year":"2024","journal-title":"Theranostics"},{"issue":"17","key":"10.1016\/j.critrevonc.2026.105513_bib39","doi-asserted-by":"crossref","first-page":"23975","DOI":"10.18632\/oncotarget.8073","article-title":"Distinct effects of SIRT1 in cancer and stromal cells on tumor promotion","volume":"7","author":"Shin","year":"2016","journal-title":"Oncotarget"},{"issue":"21","key":"10.1016\/j.critrevonc.2026.105513_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e39743","article-title":"SIRT5 participates in the suppressive tumor immune microenvironment of EGFR-mutant LUAD by regulating the succinylation of ACAT1","volume":"10","author":"Shouhan","year":"2024","journal-title":"Heliyon"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105513_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12020386","article-title":"Sirtuins Affect Cancer Stem Cells via Epigenetic Regulation of Autophagy","volume":"12","author":"Sipos","year":"2024","journal-title":"Biomedicines"},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105513_bib42","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3390\/antiox14091076","article-title":"SIRT1-Mediated Redox and Senescence Regulation in Cancer: Mechanisms and Therapeutic Implications","volume":"14","author":"Son","year":"2025","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105513_bib43","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41419-025-07656-3","article-title":"Competitive binding between DDX21 and SIRT7 enhances NAT10-mediated ac4C modification to promote colorectal cancer metastasis and angiogenesis\u2013 DDX21 promotes colorectal cancer metastasis","volume":"16","author":"Song","year":"2025","journal-title":"Cell. Death & Dis."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105513_bib44","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3390\/md21100517","article-title":"A SIRT6 Inhibitor, Marine-Derived Pyrrole-Pyridinimidazole Derivative 8a, Suppresses Angiogenesis","volume":"21","author":"Song","year":"2023","journal-title":"Mar. Drugs"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105513_bib45","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.3390\/cancers17061009","article-title":"The Role of the Sirtuin Family Histone Deacetylases in Acute Myeloid Leukemia\u2014A Promising Road Ahead","volume":"17","author":"Strza\u0142ka","year":"2025","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105513_bib46","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/s41418-025-01499-3","article-title":"Deacetylation of ANXA2 by SIRT2 desensitizes hepatocellular carcinoma cells to donafenib via promoting protective autophagy","volume":"32","author":"Sun","year":"2025","journal-title":"Cell. Death & Differ."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105513_bib47","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.7150\/ijbs.99004","article-title":"SIRT4 Controls Acetyl-CoA Synthesis to Promote Stemness and Invasiveness of Hepatocellular Carcinoma through Deacetylating MCCC2","volume":"21","author":"Sun","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105513_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1469830","article-title":"The role of SIRT1 in autophagy and drug resistance: unveiling new targets and potential biomarkers in cancer therapy","volume":"15","author":"Tang","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105513_bib49","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1124\/dmd.104.000885","article-title":"High absorption but very low bioavailability of oral resveratrol in humans","volume":"32","author":"Walle","year":"2004","journal-title":"Drug. Metab. Dispos."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105513_bib50","doi-asserted-by":"crossref","DOI":"10.1080\/15384047.2023.2235770","article-title":"SIRT1 promotes the progression and chemoresistance of colorectal cancer through the p53\/miR-101\/KPNA3 axis","volume":"24","author":"Wang","year":"2023","journal-title":"Cancer Biol. & Ther."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105513_bib51","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201948183","article-title":"SIRT2-dependent IDH1 deacetylation inhibits colorectal cancer and liver metastases","volume":"21","author":"Wang","year":"2020","journal-title":"EMBO Rep."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105513_bib52","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1159\/000493835","article-title":"Role of SIRT2 in Regulation of Stemness of Cancer Stem-Like Cells in Renal Cell Carcinoma","volume":"49","author":"Wei","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105513_bib53","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.7150\/ijbs.76704","article-title":"SIRT1 promotes glucolipid metabolic conversion to facilitate tumor development in colorectal carcinoma","volume":"19","author":"Wei","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"9-10","key":"10.1016\/j.critrevonc.2026.105513_bib54","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1007\/s10495-024-02003-x","article-title":"Glutamine deprivation in glioblastoma stem cells triggers autophagic SIRT3 degradation to epigenetically restrict CD133 expression and stemness","volume":"29","author":"Xing","year":"2024","journal-title":"Apoptosis"},{"key":"10.1016\/j.critrevonc.2026.105513_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.218193","article-title":"Cytoplasmic SIRT1 enhances the stemness of polyploid giant cancer cells by promoting \u03b2-catenin protein stability and nuclear accumulation in ovarian carcinoma upon neoadjuvant chemotherapy","volume":"639","author":"Xu","year":"2026","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105513_bib56","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/s44321-024-00051-z","article-title":"The regulatory relationship between NAMPT and PD-L1 in cancer and identification of a dual-targeting inhibitor","volume":"16","author":"Yang","year":"2024","journal-title":"EMBO Mol. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105513_bib57","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41392-023-01314-w","article-title":"SIRT7 orchestrates melanoma progression by simultaneously promoting cell survival and immune evasion via UPR activation","volume":"8","author":"Yi","year":"2023","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"11-12","key":"10.1016\/j.critrevonc.2026.105513_bib58","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s10495-022-01751-y","article-title":"The histone deacetylase SIRT6 promotes glycolysis through the HIF-1\u03b1\/HK2 signaling axis and induces erlotinib resistance in non-small cell lung cancer","volume":"27","author":"You","year":"2022","journal-title":"Apoptosis"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105513_bib59","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s13046-020-01759-9","article-title":"Inhibition of SIRT6 potentiates the anti-tumor effect of doxorubicin through suppression of the DNA damage repair pathway in osteosarcoma","volume":"39","author":"Zhang","year":"2020","journal-title":"J. Exp. & Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105513_bib60","doi-asserted-by":"crossref","first-page":"10431","DOI":"10.18632\/aging.202803","article-title":"miR-224 aggravates cancer-associated fibroblast-induced progression of non-small cell lung cancer by modulating a positive loop of the SIRT3\/AMPK\/mTOR\/HIF-1\u03b1 axis","volume":"13","author":"Zhang","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105513_bib61","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1186\/s40001-025-03236-5","article-title":"Mechanism of methyltransferase METTL14 mediating m6A modification and regulating SIRT5 expression to promote ferroptosis and repress gastric cancer progression","volume":"30","author":"Zhang","year":"2025","journal-title":"Eur. J. Med. Res."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105513_bib62","doi-asserted-by":"crossref","first-page":"182","DOI":"10.14740\/wjon2547","article-title":"Increased Sirtuin 6 Activity in Tumor Cells Can Prompt CD4-Positive T-Cell Differentiation Into Regulatory T Cells and Impede Immune Surveillance in the Microenvironment","volume":"16","author":"Zhang","year":"2025","journal-title":"World J. Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105513_bib63","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.21873\/anticanres.17098","article-title":"SIRT4 Has an Anti-Cancer Role in Cervical Cancer by Inhibiting Glutamine Metabolism via the MEK\/ERK\/C-Myc Axis","volume":"44","author":"Zhang","year":"2024","journal-title":"Anticancer. Res."},{"key":"10.1016\/j.critrevonc.2026.105513_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2026.116074","article-title":"Curcumin inhibits colorectal cancer progression by regulating MDH2-mediated glycolysis and NAD+ metabolism","volume":"213","author":"Zhao","year":"2026","journal-title":"Food Chem. Toxicol."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105513_bib65","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41589-022-01240-y","article-title":"SIRT1 deacetylates WEE1 and sensitizes cancer cells to WEE1 inhibition","volume":"19","author":"Zhu","year":"2023","journal-title":"Nat. Chem. Biol."},{"issue":"17","key":"10.1016\/j.critrevonc.2026.105513_bib66","article-title":"Metabolic-immune suppression mediated by the SIRT1-CX3CL1 axis induces functional enhancement of regulatory T cells in colorectal carcinoma","volume":"12","author":"Zi","year":"2025","journal-title":"Adv. Sci."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826004002?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826004002?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:37:25Z","timestamp":1793943445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826004002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":66,"alternative-id":["S1040842826004002"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105513","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decoding context-dependent sirtuin pharmacology in cancer: Metabolic\u2013epigenetic switches and precision therapeutic targeting","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105513","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105513"}}